AU4499196A - Antibodies for use in cancer therapy and diagnosis - Google Patents

Antibodies for use in cancer therapy and diagnosis

Info

Publication number
AU4499196A
AU4499196A AU44991/96A AU4499196A AU4499196A AU 4499196 A AU4499196 A AU 4499196A AU 44991/96 A AU44991/96 A AU 44991/96A AU 4499196 A AU4499196 A AU 4499196A AU 4499196 A AU4499196 A AU 4499196A
Authority
AU
Australia
Prior art keywords
antibodies
diagnosis
cancer therapy
cancer
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU44991/96A
Inventor
Roland Carlsson
Bo Jansson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioinvent International AB
Original Assignee
Bioinvent International AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinvent International AB filed Critical Bioinvent International AB
Publication of AU4499196A publication Critical patent/AU4499196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
    • C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU44991/96A 1995-01-18 1996-01-15 Antibodies for use in cancer therapy and diagnosis Abandoned AU4499196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9500148A SE9500148D0 (en) 1995-01-18 1995-01-18 Antibodies for use in cancer therapy and diagnosis
SE9500148 1995-01-18
PCT/SE1996/000029 WO1996022310A1 (en) 1995-01-18 1996-01-15 Antibodies for use in cancer therapy and diagnosis

Publications (1)

Publication Number Publication Date
AU4499196A true AU4499196A (en) 1996-08-07

Family

ID=20396855

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44991/96A Abandoned AU4499196A (en) 1995-01-18 1996-01-15 Antibodies for use in cancer therapy and diagnosis

Country Status (3)

Country Link
AU (1) AU4499196A (en)
SE (1) SE9500148D0 (en)
WO (1) WO1996022310A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10016877A1 (en) 2000-04-05 2001-10-18 Scintec Diagnostics Gmbh Zug (Glyco) proteins with high immunoreactivity and a process for their preparation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK172686A (en) * 1985-04-22 1986-10-23 Hybritech Inc ANTIGEN DERIVED FROM HUMAN TISSUE, PROCEDURE FOR USING THE ANTIGEN TO MAKE MONOCLONAL ANTIBODIES FOR DIAGNOSIS AND TREATMENT OF CANCER, PROCEDURE FOR DETECTION OF CANCER, AND OTHER
JPS63157995A (en) * 1986-12-18 1988-06-30 Kyowa Hakko Kogyo Co Ltd Anti-human colon carcinoma monoclonal antibody acc-574
US4892933A (en) * 1988-04-20 1990-01-09 New England Deaconess Hospital Corporation Monoclonal antibody for colorectal carcinoma
JP3137976B2 (en) * 1989-09-15 2001-02-26 ジェネティック システムズ コーポレイション Hybridoma CT43 producing monoclonal antibody against mucin epitope of colon cancer
EP0519866A1 (en) * 1991-06-18 1992-12-23 Ciba-Geigy Ag Novel anti-HIV antibodies
ZA936260B (en) * 1992-09-09 1994-03-18 Smithkline Beecham Corp Novel antibodies for conferring passive immunity against infection by a pathogen in man
AU5732694A (en) * 1992-12-01 1994-06-22 Protein Design Labs, Inc. Humanized antibodies reactive with cd18

Also Published As

Publication number Publication date
SE9500148D0 (en) 1995-01-18
WO1996022310A1 (en) 1996-07-25

Similar Documents

Publication Publication Date Title
AU5536196A (en) Cancer diagnosis and therapy based on mutations in tgf-beta receptors
AU4397297A (en) Antibody against human parathormone related peptides
PL322589A1 (en) Radiotracer-labelled peptides for use in diagnostics and therapy
AU7230196A (en) Pskh-1 ribozymes and uses in disease treatment
AU5183096A (en) Ultrasound therapy device
AU6328196A (en) Targets for breast cancer diagnosis and treatment
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU4473596A (en) Methods of human prostate cancer diagnosis
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU1810899A (en) Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
HUP9901908A3 (en) P16 expression constructs and their application in cancer therapy
AU7127196A (en) Nanoparticles in photodynamic therapy
AU2603895A (en) Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
EP0831793A4 (en) Protein particles for therapeutic and diagnostic use
AU5543494A (en) Method and kit for cancer diagnosis
AU7216996A (en) A paf-acetylhydrolase and use in therapy
AU4953693A (en) Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
AU6128896A (en) Isoindole derivatives, their preparation and their application in therapy
AU6012696A (en) Prognostic and therapeutic system for cancer
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
GB9514816D0 (en) Substances and their medical use
AU4499196A (en) Antibodies for use in cancer therapy and diagnosis
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU5554598A (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them